# Massimo Volpe

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/massimo-volpe/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,124 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 92 |
| i10-index | 580 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5054282642 |
| ORCID iD | https://orcid.org/0000-0002-9642-8380 |
| Works | 1,404 |

## Researcher papers

- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-5/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era](https://scholariq.org/papers/reduction-of-hospitalizations-for-myocardial-infarction-in-italy-in-the-covid-19/)
- [Age and Multimorbidity Predict Death Among COVID-19 Patients](https://scholariq.org/papers/age-and-multimorbidity-predict-death-among-covid-19-patients/)
- [Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years](https://scholariq.org/papers/identification-of-the-uric-acid-thresholds-predicting-an-increased-total-and/)
- [Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial](https://scholariq.org/papers/dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision-a/)
- [Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project](https://scholariq.org/papers/hyperuricemia-and-risk-of-cardiovascular-outcomes-the-experience-of-the-urrah/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.